Investment Summary |
|
|---|---|
| Date | 2018-09-05 |
| Target | SAVSU Cleo Technologies |
| Sector | Packaging |
| Investor(s) | BioLife Solutions |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 159 |
| Revenue | 82M USD (2024) |
BioLife Solutions is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. BioLife Solutions was founded in 1987 and is based in Bothell, Washington.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 7 |
| Sector: Packaging M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 2 |
| State: New Mexico M&A | 1 of 1 |
| Country: United States M&A | 1 of 6 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-14 |
Astero Bio
Menlo Park, California, United States Astero Bio Corp. is a provider in novel tools and technologies for life science research, pharmaceutical manufacturing and clinical applications. Astero specializes in the development and commercialization of next-generation tools to aid in multiple stages of the lifecycles of biologics. Astero's ThawSTAR® Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. Astero Bio Corp. was founded in 2018 and is based in Menlo Park, California. |
Buy | $21M |
